Chimeric antigen receptor T-cell therapy for mantle cell lymphoma with central nervous system involvement: Progress, but not perfect

Br J Haematol. 2023 Dec;203(5):701-703. doi: 10.1111/bjh.19095. Epub 2023 Sep 24.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adult
  • Cell- and Tissue-Based Therapy
  • Central Nervous System
  • Humans
  • Immunotherapy, Adoptive
  • Lymphoma, Mantle-Cell* / therapy
  • Receptors, Chimeric Antigen*

Substances

  • Receptors, Chimeric Antigen